|
Volumn 5, Issue 12, 2004, Pages 1311-1318
|
CYC-202 Cyclacel
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6 N,N DIMETHYLADENINE;
AMINOTRANSFERASE;
CARBOPLATIN;
CISPLATIN;
CYCLIN A;
CYCLIN B1;
CYCLIN D1;
CYCLIN DEPENDENT KINASE 7;
CYCLIN DEPENDENT KINASE 9;
CYCLIN DEPENDENT KINASE INHIBITOR;
DOCETAXEL;
DOXORUBICIN;
FLAVOPIRIDOL;
GEMCITABINE;
METHYLPREDNISOLONE;
N [5 (5 TERT BUTYL 2 OXAZOLYLMETHYLTHIO) 2 THIAZOLYL]ISONIPECOTAMIDE;
PACLITAXEL;
ROSCOVITINE;
UNCLASSIFIED DRUG;
AMINOTRANSFERASE BLOOD LEVEL;
ANTINEOPLASTIC ACTIVITY;
AREA UNDER THE CURVE;
ASTHENIA;
BREAST TUMOR;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG CONTRAINDICATION;
DRUG DISTRIBUTION;
DRUG ERUPTION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG POTENCY;
DRUG POTENTIATION;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
GLOMERULONEPHRITIS;
HEYMANN NEPHRITIS;
HUMAN;
HYPOKALEMIA;
IC 50;
INFLAMMATORY DISEASE;
KIDNEY DYSFUNCTION;
LUNG NON SMALL CELL CANCER;
LUPUS ERYTHEMATOSUS NEPHRITIS;
LYMPHATIC LEUKEMIA;
MANTLE CELL LYMPHOMA;
MITOSIS INHIBITION;
MULTIPLE MYELOMA;
NAUSEA;
NONHUMAN;
OVARY CARCINOMA;
PATENT;
PSORIASIS;
REVIEW;
SIDE EFFECT;
STRUCTURE ACTIVITY RELATION;
VOMITING;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DRUGS, INVESTIGATIONAL;
HUMANS;
PURINES;
|
EID: 11344290736
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (31)
|
References (0)
|